Format

Send to

Choose Destination
Hematol Oncol Clin North Am. 2011 Dec;25(6):1135-61, vii. doi: 10.1016/j.hoc.2011.09.018.

Diagnostic and prognostic value of cytogenetics in acute myeloid leukemia.

Author information

1
Cancer Genetics Laboratory, Department of Medical & Molecular Genetics, Guy's Hospital, King's College London School of Medicine, 8th Floor, Guy's Tower, London SE1 9RT, UK. david.grimwade@genetics.kcl.ac.uk

Abstract

The last 4 decades have seen major advances in understanding the genetic basis of acute myeloid leukemia (AML), and substantial improvements in survival of children and young adults with the disease. A key step forward was the discovery that AML cells harbor recurring cytogenetic abnormalities. The identification of the genes involved in chromosomal rearrangements has provided insights into the regulation of normal hematopoiesis and how disruption of key transcription factors and epigenetic modulators promote leukemic transformation. Cytogenetics has been widely adopted to provide the framework for development of risk-stratified treatment approaches to patient management.

PMID:
22093581
DOI:
10.1016/j.hoc.2011.09.018
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center